跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 53 条关于
“ACTRIMS”
全部
53
临床试验
28
药物
2
机构
1
资讯
22
去年
TG Therapeutics to Present New BRIUMVI Data in Multiple Sclerosis at ACTRIMS 2025 Forum
7个月前
Mapi Pharma Reports Promising Phase II Results for GA Depot in Primary Progressive Multiple Sclerosis
去年
InnoCare's Orelabrutinib Shows Over 90% Reduction in MS Brain Lesions in Phase II Trial
去年
CALLIPER Trial in Progressive MS Shows Distinct Patient Profile with Lower Inflammatory Activity
2年前
NIAID Halts Clemastine Arm of MS Trial After Fivefold Increase in Disease Progression
去年
Multiple Sclerosis Trial Analysis: Comorbidities Increase Risk of Treatment Discontinuation and Adverse Events
去年
GA Depot Shows Promise in Progressive MS with 3-Year Stability in Disability Scores
去年
GFAP Biomarker Analysis Shows Ozanimod's Impact on MS Disease Progression in ENLIGHTEN Trial
去年
Alumis' A-005 Shows Promise in Phase 1 Trial for CNS Penetration and TYK2 Inhibition
去年
Ozanimod Shows Sustained Reduction in Brain Atrophy in Relapsing Multiple Sclerosis
第 1 页,共 3 页
上一页
下一页